These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21750087)

  • 1. Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.
    Arvaniti E; Ntoufa S; Papakonstantinou N; Touloumenidou T; Laoutaris N; Anagnostopoulos A; Lamnissou K; Caligaris-Cappio F; Stamatopoulos K; Ghia P; Muzio M; Belessi C
    Haematologica; 2011 Nov; 96(11):1644-52. PubMed ID: 21750087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.
    Ntoufa S; Vardi A; Papakonstantinou N; Anagnostopoulos A; Aleporou-Marinou V; Belessi C; Ghia P; Caligaris-Cappio F; Muzio M; Stamatopoulos K
    Mol Med; 2012 Dec; 18(1):1281-91. PubMed ID: 22437326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
    Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling.
    Gordiienko I; Shlapatska L; Kholodniuk V; Sklyarenko L; Gluzman DF; Clark EA; Sidorenko SP
    PLoS One; 2017; 12(10):e0185940. PubMed ID: 28982149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 9 stimulation can induce IκBζ expression and IgM secretion in chronic lymphocytic leukemia cells.
    Fonte E; Vilia MG; Reverberi D; Sana I; Scarfò L; Ranghetti P; Orfanelli U; Cenci S; Cutrona G; Ghia P; Muzio M
    Haematologica; 2017 Nov; 102(11):1901-1912. PubMed ID: 28775123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia cells from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile in leukemic cells.
    Maffei R; Fiorcari S; Bulgarelli J; Martinelli S; Castelli I; Deaglio S; Debbia G; Fontana M; Coluccio V; Bonacorsi G; Zucchini P; Narni F; Torelli G; Luppi M; Marasca R
    Haematologica; 2012 Jun; 97(6):952-60. PubMed ID: 22207686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B Cell Anergy Modulated by TLR1/2 and the miR-17∼92 Cluster Underlies the Indolent Clinical Course of Chronic Lymphocytic Leukemia Stereotyped Subset #4.
    Ntoufa S; Papakonstantinou N; Apollonio B; Gounari M; Galigalidou C; Fonte E; Anagnostopoulos A; Belessi C; Muzio M; Ghia P; Stamatopoulos K
    J Immunol; 2016 May; 196(10):4410-7. PubMed ID: 27059597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy.
    Packham G; Krysov S; Allen A; Savelyeva N; Steele AJ; Forconi F; Stevenson FK
    Haematologica; 2014 Jul; 99(7):1138-48. PubMed ID: 24986876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathway-specific apoptotic gene expression profiling in chronic lymphocytic leukemia and follicular lymphoma.
    Hui D; Satkunam N; Al Kaptan M; Reiman T; Lai R
    Mod Pathol; 2006 Sep; 19(9):1192-202. PubMed ID: 16763612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a poor prognostic chronic lymphocytic leukemia-like disease model: PKCα subversion induces up-regulation of PKCβII expression in B lymphocytes.
    Nakagawa R; Vukovic M; Tarafdar A; Cosimo E; Dunn K; McCaig AM; Holroyd A; McClanahan F; Ramsay AG; Gribben JG; Michie AM
    Haematologica; 2015 Apr; 100(4):499-510. PubMed ID: 25616575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLAMF receptors negatively regulate B cell receptor signaling in chronic lymphocytic leukemia via recruitment of prohibitin-2.
    von Wenserski L; Schultheiß C; Bolz S; Schliffke S; Simnica D; Willscher E; Gerull H; Wolters-Eisfeld G; Riecken K; Fehse B; Altfeld M; Nollau P; Binder M
    Leukemia; 2021 Apr; 35(4):1073-1086. PubMed ID: 32826957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Akt/Mcl-1 pathway plays a prominent role in mediating antiapoptotic signals downstream of the B-cell receptor in chronic lymphocytic leukemia B cells.
    Longo PG; Laurenti L; Gobessi S; Sica S; Leone G; Efremov DG
    Blood; 2008 Jan; 111(2):846-55. PubMed ID: 17928528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of toll like receptors in chronic lymphocytic leukaemia cells.
    Muzio M; Scielzo C; Bertilaccio MT; Frenquelli M; Ghia P; Caligaris-Cappio F
    Br J Haematol; 2009 Feb; 144(4):507-16. PubMed ID: 19036098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
    Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
    Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 9 signaling in chronic lymphocytic leukemia cell lines.
    Meloni M; Sana I; Mantione ME; Riba M; Muzio M
    FEBS Open Bio; 2023 Dec; 13(12):2367-2374. PubMed ID: 37881888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease.
    Longo PG; Laurenti L; Gobessi S; Petlickovski A; Pelosi M; Chiusolo P; Sica S; Leone G; Efremov DG
    Leukemia; 2007 Jan; 21(1):110-20. PubMed ID: 17024114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal genetic program following B-cell receptor cross-linking: altered balance between proliferation and death in healthy and malignant B cells.
    Vallat LD; Park Y; Li C; Gribben JG
    Blood; 2007 May; 109(9):3989-97. PubMed ID: 17234734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia.
    Chen L; Widhopf G; Huynh L; Rassenti L; Rai KR; Weiss A; Kipps TJ
    Blood; 2002 Dec; 100(13):4609-14. PubMed ID: 12393534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different gene expression in immunoglobulin-mutated and immunoglobulin-unmutated forms of chronic lymphocytic leukemia.
    Ferrer A; Ollila J; Tobin G; Nagy B; Thunberg U; Aalto Y; Vihinen M; Vilpo J; Rosenquist R; Knuutila S
    Cancer Genet Cytogenet; 2004 Aug; 153(1):69-72. PubMed ID: 15325098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.